Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies

Vijayalakshmi Kunadian1, Azfar Zaman, Weiliang Qiu

  • 1Cardiothoracic Division, The James Cook University Hospital, Middlesbrough, UK. kunadianvijay@aol.com

Insights

Coronary artery bypass graft (CABG) surgery is a viable option for patients with severe left ventricular (LV) dysfunction. This meta-analysis shows acceptable operative mortality and 5-year survival rates for CABG in this patient group.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Clinical Outcomes Research

Background:

  • Coronary artery bypass graft (CABG) surgery is standard for severe coronary artery disease (CAD).
  • Optimal management for CAD patients with severe left ventricular (LV) dysfunction (ejection fraction [EF] ≤35%) remains unclear.
  • This meta-analysis evaluates outcomes for CABG in patients with severe LV dysfunction.

Purpose of the Study:

  • To determine operative mortality and 5-year actuarial survival for CABG in patients with severe LV dysfunction.
  • To synthesize data from observational studies on CABG outcomes in this specific patient population.

Main Methods:

  • Systematic literature search of observational studies.
  • Inclusion criteria: isolated CABG for CAD with severe LV dysfunction, reporting operative mortality and long-term survival.
  • Exclusion criteria: studies lacking pre-operative EF, insufficient survival data, or duplicate data.

Main Results:

  • 26 studies with 4119 patients (mean age 63.9 years, 82.4% male) were included.
  • Mean pre-operative EF was 24.7%.
  • On-pump CABG: 5.4% operative mortality and 73.4% 5-year survival.
  • Off-pump CABG: 4.4% operative mortality.
  • Mean post-operative EF improved to 35.19%.

Conclusions:

  • CABG can be performed with acceptable operative mortality in patients with severe LV dysfunction.
  • 5-year actuarial survival is also acceptable for this patient group.
  • Data from observational studies support CABG as a treatment option for severe LV dysfunction in CAD patients.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...